Northside Hospital Cancer Institute honored with two national recognitions

The Northside Hospital Cancer Institute has received national recognitions for quality care from Be The Match® and the Commission on Cancer (CoC) of the American College of Surgeons. I’ve attached a photo of the Cancer Institute. Please let me know if you have any questions or I can do anything else for you.

Northside Hospital BMT Program ‘significantly’ exceeds expected survival rates for 11th year

For an 11th consecutive year, The Blood and Marrow Transplant (BMT) Program at Northside Hospital Cancer Institute has been recognized as having among the best survival outcomes in the United States for bone marrow transplants.

The data was reported in the Center for International Blood and Marrow Transplant Research Final 2019 Transplant Center Survival Report and from Be The Match®.

One hundred seventy adult and pediatric transplant centers were included in the analysis of patients who received their first allogeneic transplant between January 1, 2015 and December 31, 2017 using unrelated or related donors and who had reported follow-up. The one-year survival of patients transplanted at Northside was 81.1%.

Northside is one of only two adult BMT programs in the U.S. that has achieved survival outcomes that significantly exceeded their expected survival rate for the last 11 consecutive annual reporting cycles, and Northside is the only program in Georgia to over perform.

“The BMT Program at Northside is the largest allogeneic transplant program in Georgia,” said H. Kent Holland, M.D., medical director of The BMT Program at Northside Hospital Cancer Institute. “Our success is a direct reflection of the combined experience and expertise of the teams in our inpatient and outpatient BMT units, our stem-cell laboratory and blood donor center.”

Innovative treatments and research are major components of the BMT Program at Northside. Northside offers chimeric antigen receptor (CAR) T-cell therapy and other immunotherapy treatment options including novel clinical research trials, and recently began studying an investigational treatment that uses convalescent plasma in patients currently fighting COVID-19.

Northside’s Cancer Institute receives sixth straight award for outstanding cancer care

For the sixth consecutive time, the Commission on Cancer (CoC) of the American College of Surgeons has granted its annual Outstanding Achievement Award to the Northside Hospital Cancer Institute.

Forty-eight accredited cancer programs throughout the United States received the 2019 Outstanding Achievement Award, representing approximately seven percent of programs surveyed by the CoC January 1–December 31, 2019. Northside Hospital is the only program to have received the award six times. Northside has received the recognition for every survey performed since the award’s inception in 2004 (2004, 2007, 2010, 2013, 2016 and 2019).

“These cancer programs currently represent the best of the best when it comes to cancer care,” said Lawrence N. Shulman, MD, MACP, chair of the CoC. “Each of these facilities is not just meeting nationally recognized standards for the delivery of quality cancer care, they are exceeding them.”

“This award is a direct result of the hard work of our medical staff and their ongoing commitment to provide high quality, multidisciplinary cancer care,” said Patti Owen, director of the Northside Hospital Cancer Institute. “We couldn’t be more pleased to have received it a sixth time.”

The Northside Hospital Cancer Institute is the largest and most comprehensive cancer hospital network in Georgia and a leader in cancer care. Northside ranks in the top five in the nation for newly diagnosed and/or treated cancer cases and diagnoses and treat the most new cases of cancer in Georgia.

For more information about the Northside Hospital Cancer Institute, visit builttobeatcancer.com.